Take a video tour of the Cleveland Clinics new heart center with NBBJ architects Edwin Beltran, senior associate, and Lisa Baker, ASID, IIDA. The nearly 1-million-square-foot Miller Family Pavilion serves as the main entrance to Cleveland Clinic and the new home of the Cleveland Clinic Heart & Vascular Institute. By integrating state-of-the-art clinical facilities, patient accommodations, public areas with cityscape views, and artwork throughout, the Miller Family Pavilion and Glickman Tower provide a healing environment intended to maximize the patient experience.
The Miller Pavilions shared ground floor with Glickman Tower was organized to simplify patient and staff navigation by establishing self-evident circulation paths. The double-height main lobby is bright with soaring luminous white walls, terrazzo floors, frosted interior glass, and floor-to-ceiling windows that infuse the space with natural light.
Cleveland Clinic Pediatric Radiology provides unique benefits not only do we feel more comfortable dealing with children and have full skill sets and are pediatric trained. We are also aware that children have different diseases than adults, need a different level of education for different procedures and different skill set for the operators who are performing the procedures. Cleveland Clinic Pediatric Radiology offers a unique set of sub-specialty services to our institution, Fetal MRI, Vascular Anomalies Imaging, Ultrasound-guided Joint Injection. http://bit.ly/pediatric-radiology
Initial options for treating chronic lymphocytic leukemia (CLL) depend in part on the patient's age, disease stage, level of fitness and ability to tolerate the therapy. In this video, Mitchell Smith, MD, PhD, Director of Cleveland Clinic Taussig Cancer Institute's Lymphoid Malignancy Program, discusses research results from the American Society of Hematology's (ASH) December 2013 Annual Meeting addressing whether fludarabine, cyclophosphamide and rituximab (FCR) should be the treatment of choice for young, fit CLL patients. Dr. Smith also reviews research findings from ASH about the best initial therapy for elderly, less-fit CLL patients.
Brian Bolwell, MD, Chair, Taussig Cancer Institute, discusses the current state of personalized medicine.
➨ Visit Cleveland Clinic: http://bit.ly/XlxDfr
➨ Visit Health Hub from Cleveland Clinic: http://bit.ly/VBQ3nW